Toxoplasma gondii

From IDWiki
Toxoplasma gondii /
Revision as of 12:04, 19 September 2019 by Aidan (talk | contribs) (: initial)
  • Protozoan parasite associated with cats and raw beef mostly known for causing opportunistic infections and congenital infections

Microbiology

  • Protozoan parasite
  • Organized into twelve haplotypes

Epidemiology

  • Zoonotic disease with worldwide distribution
  • Modes of transmission
    • Ingesting tissue cysts in meat, or oocytes in food or water
    • Solid-organ transplantation, especially heart
    • Vertical or transplacental transmission
    • Case reports of lab-acquired needlestick transmission
    • Theoretical risk with blood transfusion
  • Seroprevalence around 10-18% in Canada 12
    • As high as 60% in Nunavut, however 3
  • There are large parts of South and Central America, as well as Pacific Islands, that have very high seroprevalence 4

Life Cycle

  • The only definitive hosts are in the Felidae family, essentially housecats and their relatives
  • Intermediate hosts are many, and include birds and rodents
  • An infected cat sheds oocytes into the environment (for 1 to 3 weeks), where they spend 1 to 5 days sporulating
    • Each sporulated oocyst contains two sporocysts, and each sporocyst contains four sporozoites
  • Intermediate hosts ingest the sporozoites, where they mature into tachyzoites
  • Tachyzoites migrate to brain and muscle, where they encyst and become bradyzoites
  • Bradyzoites are ingested by a cat, completing the life cycle

Pathophysiology

  • Following ingestion, bradyzoites and sporozoites invade the small intestinal mucosa and develop into tachyzoites within the gut epithelium
  • There, they insert themselves into monocytes and other nucleated cells
  • Infected cells travel throughout the body, carrying the tachyzoite with them
  • Infection triggers a Th-1 response

Clinical Presentation

Immunocompetent

  • Asymptomatic in 80% of primary infections
  • Symptoms, when they occur, can involve fever, cervical lymphadenopathy, myalgias, and weakness/fatigue
  • Can also cause chorioretinitis
  • Severity of illness depends in part on genotype, with strain II in North America and Europe being less severe
    • Rarely, unusual strains may cause pneumonitis, myocarditis, meningoencephalitis, or polymyositis, and can lead to death

Immunocompromised

  • May be from primary infection or, more commonly, reactivation
  • Unlike in immunocompetent people, it is always a serious infection in the immunocompromised
  • Major risk factor is cellular immunodeficiency, as in HIV and some immunosuppressive medications
    • In HIV, beware with CD4 < 100
  • Typically presents with CNS involvement as encephalitis
    • Symptoms include fever, headache, lethargy, incoordination, ataxia, hemiparesis, loss of memory, dementia, or seizures
  • Can also present with pneumonitis, chorioretinitis, or myocarditis, and rarely involves essentially any other organ

Pregnancy

  • As with other immunocompetent people, it is largely asymptomatic
  • Only half of women can identify a significant risk factor 5
  • Can cause fetal loss
  • Risk of transmission to fetus is with parasitemia associated with primary infection, so women who are seropositive are not at risk of having a child with congenital infection

Congenital

  • Can be acquired during maternal parasitemia associated with primary infection
    • Risk of transplacental infection of fetus is lowest in first trimester and highest in third
  • 85% of infected babies are asymptomatic at birth; 15% symptomatic
    • Symptom severity increases is highest in first trimester and lowest in third
  • Classic triad of chorioretinitis (most common), intraparenchymal cerebral calcifications, and hydrocephalus
  • Others: thrombocytopenia, hepatitis, hepatosplenomegaly

Diagnosis

  • Immunocompetent or pregnant women with primary infection: IgG/IgM serology, possibly with avidity testing for pregnant women
  • Fetus, to rule out congenital infection following maternal primary infection: PCR of amniotic fluid
  • Newborn, to rule out congenital infection: PCR of placenta or cord, or serology
  • Immunocompromised patient, to diagnose cerebral or disseminated disease: PCR of blood, CSF, BAL, or tissue
  • Patient with chorioretinitis: Parallel serologies from aqueous humour and serum, or PCR of aqueous humour

Serology

  • IgM titres plateau within 1 month, and IgG within 2-3 months
  • IgM is still detectable for months or years after infection
  • IgM avidity testing can help to assess how recently the infection was acquired
    • Provides a measure of how tightly the antibodies bind, which is highest in early infection
    • A high avidity ratio (weak binding) suggests that the infection was acquired at least 4 months prior

Management

  • First-line is a combination of pyrimethamine and sulfadiazine
  • Alternatives
  • Dosing
    • Encephalitis: pyrimethamine 200 mg load followed by 50-75 mg/day
    • Infection during pregnancy: pyrimethamine 100 mg daily for 2 days followed by 25 to 50 mg/day

Prevention

  • Cats: hand hygiene after handling cat, use gloves and wash hands when handling litter, wash litter tray with hot >60ºC water, keep litter out of kitchen
  • Soil: use gloves for gardening, wash hands after soil contact
  • Water: avoid tap water in highly endemic countries, avoid ingestion of lake and river water
  • Food: avoid raw oysters/clams/mussels, wash all vegetables/fruits/herbs, cook meat well down

Further Reading

  • Epidemiology of and Diagnostic Strategies for Toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264. doi: [10.1128/CMR.05013-11]

References

  1. ^  Samar Shuhaiber, Gideon Koren, Rada Boskovic, Thomas R Einarson, Offie Porat Soldin, Adrienne Einarson. Seroprevalence of Toxoplasma gondiiinfection among veterinary staff in Ontario, Canada (2002): Implications for teratogenic risk. BMC Infectious Diseases. 2003;3(1). doi:10.1186/1471-2334-3-8.
  2. ^  EL Ford-Jones, I Kitai, M Corey, R Notenboom, N Hollander, E Kelly, H Akoury, G Ryan, I Kyle, R Gold. Seroprevalence of Toxoplasma Antibody in a Toronto Population. Canadian Journal of Infectious Diseases. 1996;7(5):326-328. doi:10.1155/1996/172651.
  3. ^  V. Messier, B. Lévesque, J.-F. Proulx, L. Rochette, M. D. Libman, B. J. Ward, B. Serhir, M. Couillard, N. H. Ogden, É. Dewailly, B. Hubert, S. Déry, C. Barthe, D. Murphy, B. Dixon. Seroprevalence of Toxoplasma gondii Among Nunavik Inuit (Canada). Zoonoses and Public Health. 2009;56(4):188-197. doi:10.1111/j.1863-2378.2008.01177.x.
  4. ^  Georgios Pappas, Nikos Roussos, Matthew E. Falagas. Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. International Journal for Parasitology. 2009;39(12):1385-1394. doi:10.1016/j.ijpara.2009.04.003.
  5. ^  K. Boyer, D. Hill, E. Mui, K. Wroblewski, T. Karrison, J. P. Dubey, M. Sautter, A. G. Noble, S. Withers, C. Swisher, P. Heydemann, T. Hosten, J. Babiarz, D. Lee, P. Meier, R. McLeod. Unrecognized Ingestion of Toxoplasma gondii Oocysts Leads to Congenital Toxoplasmosis and Causes Epidemics in North America. Clinical Infectious Diseases. 2011;53(11):1081-1089. doi:10.1093/cid/cir667.